Biotechnology · Healthcare
Board Member, CEO
Board Member
Cogent Biosciences, Inc. (COGT)Equibles does not estimate personal net worth.
Get an email with a short summary when Cogent Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get COGT alertsAndrew Robbins is recorded as Board Member and CEO at Cogent Biosciences, Inc. (COGT). The newest filing on record that lists Andrew Robbins as Board Member and CEO at Cogent Biosciences, Inc. (COGT) is dated April 23, 2026. The proxy statement of Cogent Biosciences, Inc. reports total compensation of $27,762,684 for Andrew Robbins in fiscal 2025, including a base salary of $724,554. Disclosed compensation is on record for 6 fiscal years. Andrew Robbins has spoken on 1 investor event across 1 company, most recently for Cogent Biosciences, Inc. on June 3, 2026. Cogent Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cogent Biosciences, Inc. includes Peter Harwin (Chairman and Board Member), John Green (CFO), John L. Green (CFO) and 7 others.
“And just a very sort of high-level introduction to the company. For those that aren't as familiar, we are a company focused on creating novel small molecule treatments for patients with rare diseases caused by mutations, both within and outside of the cancer field.”
Start not stated–present
Last confirmed April 23, 2026
Start not stated–present
Last confirmed April 23, 2026
Biotechnology · Healthcare
Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cogent Biosciences, Inc. (COGT) | Chief Executive Officer | $724,554 | $27,762,684 |
| 2024 | Cogent Biosciences, Inc. (COGT) | Chief Executive Officer | $692,000 | $4,917,890 |
| 2023 | Cogent Biosciences, Inc. (COGT) | Chief Executive Officer | $656,098 | $7,898,772 |
| 2022 | Cogent Biosciences, Inc. (COGT) | Chief Executive Officer | $624,283 | $4,391,176 |
| 2021 | Cogent Biosciences, Inc. (COGT) | Chief Executive Officer | $592,648 | $2,862,878 |
| 2020 | Cogent Biosciences, Inc. (COGT) | Chief Executive Officer | $101,731 | $17,859,744 |